Searching for the hidden heart risk in kids who beat cancer
NCT ID NCT07253077
Summary
This study aims to find early warning signs in the blood that could predict future heart damage in children and teens who were successfully treated for cancer with a type of drug called anthracyclines. Researchers will compare blood tests and heart scans from 40 young cancer survivors with those from healthy children to see if specific markers appear before heart problems develop. The goal is to learn how to spot heart risks earlier, allowing for better monitoring and care for survivors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPEUTIC TOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.